Maureen Baldwin, MD, MPH, Oregon Health & Science University

Objective: To identify whether early placental and endometrial biomarkers that can indicate intrauterine versus ectopic pregnancy can be detected in cervical mucus samples from women in early pregnancy and with pregnancy of unknown location. Methods: This study will be conducted at Oregon Health and Science University and Planned Parenthood of the Colombia-Willamette sites in Portland, ...Read more >

Kristen Daskilewicz, MPH, University of Cape Town

Abortion is a leading cause of maternal mortality in Botswana, where legal abortion is restricted. Post-abortion care services are provided by government hospitals for complications following unsafe abortion. The health services are flooded with women presenting with diagnoses of spontaneous, threatened, or incomplete abortion, accounting for more than half of admissions to gynecology wards. Recent ...Read more >

Lori Freedman, PhD, University of California, San Francisco

Catholic hospitals care for one in six US patients and follow the Ethical and Religious Directives for Catholic Healthcare Services, which prohibit abortion, contraception, sterilization, and certain treatment for obstetrical complications. Defenders of institutions’ rights to refuse this care argue that women can simply choose other providers. But, if women are not aware of the ...Read more >

Maryam Guiahi, MD, MSc, University of Colorado

In my early career, I examined the negative impact that institutional restrictions at faith-based hospitals have on obstetrics and gynecology residency training and the subsequent care graduates provide to women, including quantitative and qualitative studies of current trainees and recent graduates. Through the research and training activities proposed in this award, I will investigate solutions ...Read more >

Caitlin Gerdts, PhD, MHS, Ibis Reproductive Health

The number of women seeking medication abortion and alternative methods of self-induction is increasing rapidly around the world, particularly in contexts where abortion is highly restricted or where abortion is legally available but inaccessible, such as South Africa. Despite these trends, there is a lack of understanding of women’s experiences with informal sector abortion; furthermore, ...Read more >

Sabrina Holmquist, MD, MPH, University of Chicago

Objectives: Define a set of developmental milestones to measure progress through the family planning fellowship and determine readiness for independent practice based on consensus from a majority of fellowship program directors. Methods: Three rounds of surveys were conducted using the Delphi method: Round one solicited both quantitative and qualitative responses concerning the number and content ...Read more >

Paula Bednarek, MD, MPH, Oregon Health & Science University

Objectives: To compare pain control during cervical dilation between two paracervical block (PCB) techniques among women undergoing first trimester surgical abortion. Our research group established the benefit of a specific PCB technique: 20mL 1% buffered lidocaine (2mL at tenaculum site, 18mL paracervical at 4-sites), with a 3 minute wait prior to cervical dilation (PCB 20/4/3). ...Read more >

Anu Kumar, PhD, MPH, Ipas

Background: Abortion stigma is a complex issue, and understanding its manifestation and perpetuation is challenging. However, abortion stigma may have profound social and health consequences for women and it is important for us to better understand it. When faced with unplanned or unhealthy pregnancies, fear of stigma may prevent women from seeking early safe abortions, ...Read more >

Gillian Dean, MD, MPH, Planned Parenthood of New York City

Objective: To determine whether manual vacuum aspiration (MVA) or electric vacuum aspiration (EVA) improves physicians’ ability to accurately identify products of conception (POC) in abortions at less than 6 weeks’ gestation. Methods: 498 pregnant women presenting for surgical abortion with mean gestational sac diameter of

Jennifer Kerns, MD, MPH, MS, University of California, San Francisco

Inducing fetal demise before abortion in the later second trimester is a common practice despite its unproven utility. Digoxin is the most commonly used feticidal agent among family planning subspecialists, with intrafetal administration more effective at achieving fetal demise than the intra-amniotic route. Reasons for inducing fetal demise before abortion in the later second trimester ...Read more >

1 93 94 95 96 97 104